OGN Organon & Co. Common Stock
$13,72
Harga · Agu 19, 2026
Fundamental per Jul 31, 2026
Rentang 52M
$6–$14
100% of range
Peringkat Analis
HOLD
13 analysts
Target Harga
$11
P/E (TTM)
19.1
ROE
25.2%
Margin Laba Bersih
3.0%
Tentang Organon & Co. Common Stock Tinjauan perusahaan dari Wikipedia
Organon & Co. adalah perusahaan farmasi Amerika Serikat yang berkantor pusat di Jersey City, New Jersey. Organon mengkhususkan diri dalam bidang terapi inti berikut: kesehatan reproduksi, kontrasepsi, psikiatri, terapi penggantian hormon (HRT), dan anestesi. Organon menjual ke pasar internasional.
Baca selengkapnya
Organon & Co. adalah perusahaan farmasi Amerika Serikat yang berkantor pusat di Jersey City, New Jersey. Organon mengkhususkan diri dalam bidang terapi inti berikut: kesehatan reproduksi , kontrasepsi, psikiatri, terapi penggantian hormon (HRT), dan anestesi. Organon menjual ke pasar internasional.
Organon didirikan oleh Dr. Saal van Zwanenberg di Oss, Belanda, pada tahun 1923 sebagai bagian terpisah dari pabrik daging Zwanenberg's fabrieken. Produk pertamanya adalah insulin pada tahun 1923. Pada tahun 1930-an Organon memproduksi estrogen.
Pada tahun 1948, Organon mengakuisisi situs penelitian Newhouse di Skotlandia, Britania Raya. Produksi kortison dimulai pada tahun 1953.
Pada tahun 1962, ia membeli saham Nederlandsche Cocaïnefabriek (Pabrik Kokain Belanda). Nama perusahaan diubah menjadi Koninklijke Zwanenberg-Organon (KZO), dan merger dengan produsen serat AKU pada tahun 1969 menjadi AKZO, kemudian Akzo Nobel. Organon adalah unit bisnis perawatan kesehatan manusia Akzo Nobel. Pada tahun 2004, Organon mengakuisisi produsen bahan aktif farmasi Diosynth.
Pada November 2007, Schering-Plough mengakuisisi Organon BioSciences dan perusahaan farmasi veteriner Intervet dari Akzo Nobel. Schering-Plough memindahkan Organon ke markas besarnya di New Jersey. Dua tahun kemudian, Schering-Plough bergabung dengan Merck & Co., yang dikenal sebagai Merck Sharp & Dohme atau MSD di luar Amerika Serikat dan Kanada.
Pada Mei 2020, Merck & Co. mengumumkan bahwa Organon & Co. akan menjadi nama sempalan (spin-off) yang tertunda dari bisnis kesehatan wanita, produk warisan, dan biosimilar, yang menurut perusahaan akan "diselesaikan pada akhir paruh pertama tahun 2021." Merck menyelesaikan spin-off tersebut dan Organon & Co. menjadi perusahaan publik pada 3 Juni 2021.
Pada November 2021, perusahaan tersebut mengumumkan akan mengakuisisi Forendo Pharma dan senyawa utamanya, inhibitor 17β-hydroxysteroid dehydrogenase tipe 1 oral yang berpotensi pertama di kelasnya.
Produk
Produk-produknya meliputi: Esmirtazapine, Remeron, Remeron SolTab, Sustanon, Deca-Durabolin, Pregnyl, Implanon, NuvaRing, Marvelon, Desolett dan berbagai produk kontrasepsi lainnya.
Lihat juga
Nederlandsche Cocaïnefabriek
Referensi
Pranala luar
Merck announces Organon as name for new spinoff
Photo of Organon Insulin carton, 1930
Report to the Insulin Committee on Insulins in Europe, 1925 (University of Toronto)-page 26-Organon
Sumber: Wikipedia, CC BY-SA 4.0 · Lihat di Wikipedia ↗
OGN Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$13.72
Kapitalisasi Pasar
$3.57B
P/E (TTM)
19.1
EPS (TTM)
$0.72
Pendapatan (TTM)
$6.22B
Imbal Hasil Dividen
2.5%
ROE
25.2%
D/E Utang/Ekuitas
11.5
Rentang 52M
$6 – $14
OGN Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
$6.22B
2019-12-31
→
2025-12-31
EPS
$0.72
2019-12-31
→
2025-12-31
Arus Kas Bebas
$538M
2021-12-31
→
2025-12-31
Margin
3.0%
2024-12-31
→
2025-12-31
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
OGN
Median Rekan
P/E (TTM)
19.1
38.7
P/S (TTM)
0.6
9.5
P/B
4.7
3.8
Price / FCF (Harga / FCF)
6.6
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
OGN
Median Rekan
Gross Margin (Margin Kotor)
53.3%
82.0%
Net Profit Margin (Margin Laba Bersih)
3.0%
15.3%
ROA
1.4%
-6.4%
ROE
25.2%
-16.8%
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
OGN
Median Rekan
Debt / Equity (Utang / Ekuitas)
11.5
—
Current Ratio (Rasio Lancar)
1.8
12.8
Quick Ratio (Rasio Cepat)
0.8
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
OGN
Median Rekan
Revenue YoY (Pendapatan YoY)
-2.9%
—
Revenue CAGR 3Y (CAGR Pendapatan 3T)
0.23%
—
Revenue CAGR 5Y (CAGR Pendapatan 5T)
-0.99%
—
EPS YoY
-78.4%
—
Net Income YoY (Laba Bersih YoY)
-78.4%
—
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
OGN
Median Rekan
Payout Ratio (Rasio Pembayaran Dividen)
47.1%
—
Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun
Imbal Hasil Dividen
2.5%
Rasio Pembayaran Dividen
47.1%
CAGR Dividen 5T
—
| Tanggal ex-dividen | Jumlah |
|---|---|
| 14 Agu 2026 | $0,0200 |
| 11 Mei 2026 | $0,0200 |
| 23 Feb. 2026 | $0,0200 |
| 20 Nov. 2025 | $0,0200 |
| 15 Agu 2025 | $0,0200 |
| 12 Mei 2025 | $0,0200 |
| 24 Feb. 2025 | $0,2800 |
| 12 Nov. 2024 | $0,2800 |
| 16 Agu 2024 | $0,2800 |
| 10 Mei 2024 | $0,2800 |
| 23 Feb. 2024 | $0,2800 |
| 10 Nov. 2023 | $0,2800 |
| 17 Agu 2023 | $0,2800 |
| 12 Mei 2023 | $0,2800 |
| 24 Feb. 2023 | $0,2800 |
| 10 Nov. 2022 | $0,2800 |
| 12 Agu 2022 | $0,2800 |
| 13 Mei 2022 | $0,2800 |
| 25 Feb. 2022 | $0,2800 |
| 19 Nov. 2021 | $0,2800 |
OGN Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
JUAL
13 analis
- Beli Kuat 0 0,0%
- Beli 0 0,0%
- Tahan 7 53,8%
- Jual 5 38,5%
- Jual Kuat 1 7,7%
Target Harga 12 Bulan
4 analis · 2026-08-19
Median
$11.50
Sekarang
$13.72
Rendah
$8.00
Tinggi
$14.00
Target median
$11.50
-16,2%
Target rata-rata
$11.25
-18,0%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.01%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $0.85 | $0.93 | -0.08% |
| 31 Maret 2026 | $0.71 | $0.84 | -0.13% |
| 31 Des. 2025 | $0.63 | $0.73 | -0.10% |
| 30 Sep. 2025 | $1.01 | $0.95 | 0.06% |
| 30 Juni 2025 | $1.00 | $0.96 | 0.04% |
| 31 Maret 2025 | $1.02 | $0.91 | 0.11% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| MANE | — | — | — | — | 82.6% | — |
| INDV | — | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| ELVN | $915M | -8.4 | — | — | -21.9% | — |
| AMLX | $1.33B | -7.9 | -77.1% | — | -61.2% | — |
| GPCR | $14.78B | -86.9 | — | — | -12.3% | — |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | — |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 13
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $6.22B | $6.40B | $6.26B | $6.17B | $6.30B | $6.53B | |
| Cost of Revenue | $2.90B | $2.69B | $2.52B | $2.29B | $2.38B | $2.12B | |
| Gross Profit | $3.31B | $3.71B | $3.75B | $3.88B | · | · | |
| R&D Expense | · | · | · | · | $443M | $210M | |
| SG&A Expense | $1.72B | $1.76B | $1.89B | $1.70B | $1.67B | $1.36B | |
| Interest Expense | $504M | $520M | $527M | $422M | $258M | $0 | |
| Pretax Income | $425M | $807M | $673M | $1.12B | $1.53B | $2.75B | |
| Income Tax | $238M | $-57M | $-350M | $205M | $178M | $496M | |
| Net Income | $187M | $864M | $1.02B | $917M | $1.35B | $2.16B | |
| EPS (Basic) | $0.72 | $3.36 | $4.01 | $3.61 | $5.33 | $8.52 | |
| EPS (Diluted) | $0.72 | $3.33 | $3.99 | $3.59 | $5.31 | $8.52 | |
| Shares (Basic) | 259,495,000 | 257,046,000 | 255,239,000 | 254,082,000 | 253,538,000 | 253,516,000 | |
| Shares (Diluted) | 260,764,000 | 259,152,000 | 256,270,000 | 255,169,000 | 254,193,000 | 253,516,000 |
Neraca 25
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $574M | $675M | $693M | $706M | $737M | $12M | |
| Receivables | $1.33B | $1.36B | $1.74B | $1.48B | $1.38B | $1.04B | |
| Inventory | $1.41B | $1.32B | $1.31B | $1.00B | $915M | $913M | |
| Other Current Assets | $1.03B | $994M | $756M | $747M | $726M | $930M | |
| Current Assets | $4.35B | $4.35B | $4.51B | $3.93B | $3.76B | $3.57B | |
| PP&E (Net) | $1.30B | $1.17B | $1.18B | $1.02B | $973M | $984M | |
| Accum. Depreciation | $1.24B | $1.06B | $1.02B | $902M | $882M | $820M | |
| Goodwill | $4.15B | $4.68B | $4.60B | $4.60B | $4.60B | $4.60B | |
| Intangibles | $1.13B | $1.41B | $533M | $649M | $651M | $503M | |
| Total Assets | $12.87B | $13.10B | $12.06B | $10.96B | $10.68B | $10.11B | |
| Accounts Payable | $952M | $1.15B | $1.31B | $1.13B | $1.38B | $259M | |
| Current Liabilities | $2.39B | $2.72B | $2.92B | $2.51B | $2.60B | $2.67B | |
| Capital Leases | $116M | $112M | $125M | $150M | $184M | $23M | |
| Deferred Tax | $57M | $74M | $47M | $19M | $4M | $128M | |
| Other Non-current Liabilities | $1.01B | $977M | $412M | $411M | $463M | $1.74B | |
| Total Liabilities | $12.12B | $12.63B | $12.13B | $11.85B | · | · | |
| Long-term Debt | $8.64B | $8.88B | $8.76B | $8.91B | $9.13B | $0 | |
| Total Debt | $8.63B | $20M | $8.76B | $8.91B | $9.13B | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $0 | |
| Paid-in Capital | · | · | · | · | $0 | $0 | |
| Retained Earnings | $1.11B | $1.01B | $443M | $-331M | $-998M | $0 | |
| AOCI | $-527M | $-649M | $-541M | $-564M | $-513M | $-622M | |
| Stockholders' Equity | $752M | $472M | $-70M | $-892M | $-1.51B | $5.49B | |
| Liabilities + Equity | $12.87B | $13.10B | $12.06B | $10.96B | $10.68B | $10.11B | |
| Shares Outstanding | 260,316,000 | 257,799,000 | 255,626,000 | 254,370,000 | 253,550,000 | · |
Arus Kas 15
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $77M | $105M | $101M | $75M | $59M | $40M | |
| Deferred Tax | $63M | $-160M | $-485M | $-18M | $-288M | $-32M | |
| Amort. of Intangibles | $205M | $145M | $116M | $116M | $103M | $86M | |
| Restructuring | $95M | $31M | $62M | $28M | $3M | $60M | |
| Operating Cash Flow | $700M | $939M | $799M | $858M | $2.16B | $2.28B | |
| CapEx | $162M | $175M | $251M | $196M | $192M | $255M | |
| Investing Cash Flow | $-390M | $-513M | $-260M | $-420M | · | · | |
| Debt Issued | $1.05B | $1.19B | $80M | $0 | $9.47B | $0 | |
| Net Debt Issued | $-458M | $-11M | $-258M | $-108M | $9.36B | · | |
| Dividends Paid | $88M | $297M | $294M | $290M | $145M | $0 | |
| Financing Cash Flow | $-561M | $-368M | $-569M | $-433M | · | · | |
| Net Change in Cash | $-101M | $-18M | $-13M | $-31M | $667M | $-249M | |
| Taxes Paid | $287M | · | · | · | · | · | |
| Free Cash Flow | $538M | $764M | $548M | $662M | $1.97B | · | |
| Levered FCF | $316M | $207M | $-253M | $317M | $1.74B | · |
Profitabilitas 5
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 53.3% | 58.0% | · | · | · | · | |
| Net Margin | 3.0% | 13.5% | 16.3% | 14.8% | 21.4% | · | |
| Pretax Margin | 6.8% | 12.6% | 10.8% | 18.2% | 24.2% | · | |
| ROA | 1.4% | · | 8.9% | 8.5% | 13.0% | · | |
| ROE | 25.2% | · | -310.5% | -93.7% | -86.4% | · |
Likuiditas & Solvabilitas 4
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | · | 1.5 | 1.6 | 1.4 | · | |
| Quick Ratio | 0.8 | · | 0.8 | 0.9 | 0.8 | · | |
| Debt / Equity | 11.5 | · | -125.1 | -10.0 | -6.1 | · | |
| LT Debt / Equity | 11.5 | · | -125.0 | -10.0 | -6.1 | · |
Efisiensi 3
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.5 | 0.6 | 0.6 | · | |
| Inventory Turnover | 2.1 | · | 2.2 | 2.4 | 2.6 | · | |
| Receivables Turnover | 4.6 | · | 3.9 | 4.3 | 5.2 | · |
Tingkat Pertumbuhan 9
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.9% | 2.2% | 1.4% | -2.1% | -3.5% | · | |
| Revenue CAGR 3Y | 0.23% | 0.52% | -1.4% | · | · | · | |
| Revenue CAGR 5Y | -0.99% | · | · | · | · | · | |
| EPS YoY | -78.4% | -16.5% | 11.1% | -32.4% | -37.7% | · | |
| EPS CAGR 3Y | -41.5% | -14.4% | -22.3% | · | · | · | |
| EPS CAGR 5Y | -39.0% | · | · | · | · | · | |
| Net Income YoY | -78.4% | -15.5% | 11.6% | -32.1% | -37.5% | · | |
| Net Income CAGR 3Y | -41.1% | -13.8% | -22.1% | · | · | · | |
| Net Income CAGR 5Y | -38.7% | · | · | · | · | · |
Valuasi (TTM) 15
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.22B | $6.40B | $6.26B | $6.17B | $6.30B | · | |
| Net Income TTM | $187M | $864M | $1.02B | $917M | $1.35B | · | |
| Market Cap | $1.87B | · | $3.69B | $7.10B | $7.72B | · | |
| Enterprise Value | $9.92B | · | $11.75B | $15.31B | $16.12B | · | |
| P/E | 10.0 | 4.5 | 3.6 | 7.8 | 5.7 | · | |
| P/S | 0.3 | · | 0.6 | 1.2 | 1.2 | · | |
| P/B | 2.5 | · | -52.7 | -8.0 | -5.1 | · | |
| P / Cash Flow | 2.7 | · | 4.6 | 8.3 | 3.6 | · | |
| P / FCF | 3.5 | · | 6.7 | 10.7 | 3.9 | · | |
| EV / FCF | 18.4 | · | 21.4 | 23.1 | 8.2 | · | |
| EV / Revenue | 1.6 | · | 1.9 | 2.5 | 2.6 | · | |
| Dividend Yield | 4.7% | · | 8.0% | 4.1% | 1.9% | · | |
| Earnings Yield | 10.0% | 22.3% | 27.7% | 12.8% | 17.4% | · | |
| Payout Ratio | 47.1% | 34.4% | 28.7% | 31.6% | 10.7% | · | |
| Annual Payout | $88M | $297M | $294M | $290M | $145M | · |
Laporan Laba Rugi 12
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.56B | $1.46B | $1.51B | $1.60B | $1.59B | $1.51B | $1.59B | $1.58B | $1.61B | $1.62B | $1.60B | $1.52B | $1.61B | $1.54B | $1.49B | $1.54B | |
| Cost of Revenue | $711M | $677M | $766M | $745M | $720M | $672M | $696M | $659M | $668M | $665M | $683M | $612M | $640M | $580M | $594M | $551M | |
| Gross Profit | $847M | $783M | $741M | $857M | $874M | $841M | $896M | $923M | $939M | $957M | $915M | $907M | $968M | · | · | · | |
| SG&A Expense | $434M | $424M | $433M | $415M | $453M | $420M | $470M | $422M | $437M | $431M | $469M | $538M | $451M | $435M | $470M | $440M | |
| Interest Expense | $108M | $111M | $121M | $128M | $131M | $124M | $132M | $126M | $131M | $131M | $129M | $134M | $132M | $132M | $119M | $108M | |
| Pretax Income | $183M | $213M | $-148M | $243M | $229M | $101M | $129M | $207M | $235M | $236M | $104M | $80M | $254M | $235M | $111M | $282M | |
| Income Tax | $75M | $67M | $57M | $83M | $84M | $14M | $20M | $-152M | $40M | $35M | $-442M | $22M | $12M | $58M | $3M | $55M | |
| Net Income | $108M | $146M | $-205M | $160M | $145M | $87M | $109M | $359M | $195M | $201M | $546M | $58M | $242M | $177M | $108M | $227M | |
| EPS (Basic) | $0.41 | $0.56 | $-0.79 | $0.61 | $0.56 | $0.34 | $0.43 | $1.39 | $0.76 | $0.78 | $2.13 | $0.23 | $0.95 | $0.70 | $0.43 | $0.89 | |
| EPS (Diluted) | $0.40 | $0.55 | $-0.78 | $0.61 | $0.56 | $0.33 | $0.42 | $1.38 | $0.75 | $0.78 | $2.12 | $0.23 | $0.95 | $0.69 | $0.42 | $0.89 | |
| Shares (Basic) | 262,611,000 | 260,370,000 | -518,281,000 | 259,975,000 | 259,939,000 | 257,862,000 | -513,435,000 | 257,498,000 | 257,288,000 | 255,695,000 | -510,082,000 | 255,588,000 | 255,341,000 | 254,392,000 | -507,867,000 | 254,348,000 | |
| Shares (Diluted) | 270,449,000 | 262,896,000 | -521,046,000 | 260,653,000 | 260,156,000 | 261,001,000 | -517,565,000 | 259,757,000 | 258,598,000 | 258,362,000 | -512,202,000 | 256,349,000 | 255,953,000 | 256,170,000 | -510,106,000 | 255,067,000 |
Neraca 24
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.13B | $1.12B | $574M | $672M | $599M | $547M | $675M | $763M | $704M | $575M | · | $414M | $326M | $459M | · | $499M | |
| Receivables | $1.49B | $1.38B | $1.33B | $1.48B | $1.48B | $1.46B | $1.36B | $1.69B | $1.62B | $1.55B | · | $1.65B | $1.67B | $1.45B | · | $1.44B | |
| Inventory | $1.35B | $1.37B | $1.41B | $1.49B | $1.45B | $1.36B | $1.32B | $1.38B | $1.29B | $1.26B | · | $1.19B | $1.20B | $1.12B | · | $879M | |
| Other Current Assets | $1.14B | $1.06B | $1.03B | $1.06B | $1.08B | $1.00B | $994M | $925M | $901M | $811M | · | $802M | $761M | $755M | · | $774M | |
| Current Assets | $5.11B | $4.93B | $4.35B | $4.70B | $4.62B | $4.37B | $4.35B | $4.76B | $4.51B | $4.20B | · | $4.05B | $3.96B | $3.78B | · | $3.59B | |
| PP&E (Net) | $1.28B | $1.28B | $1.30B | $1.29B | $1.27B | $1.20B | $1.17B | $1.20B | $1.16B | $1.18B | · | $1.10B | $1.11B | $1.05B | · | $906M | |
| Accum. Depreciation | · | · | $1.24B | · | · | · | $1.06B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $4.15B | $4.15B | $4.15B | $4.68B | $4.68B | $4.68B | $4.68B | $4.60B | $4.60B | $4.60B | $4.60B | $4.60B | $4.60B | $4.60B | · | $4.60B | |
| Intangibles | $1.11B | $1.10B | $1.13B | $1.34B | $1.36B | $1.42B | $1.41B | $763M | $684M | $718M | · | $561M | $592M | $621M | · | $670M | |
| Total Assets | $13.18B | $13.00B | $12.87B | $13.55B | $13.50B | $13.16B | $13.10B | $12.75B | $12.15B | $11.89B | · | $11.01B | $10.98B | $10.76B | · | $10.44B | |
| Accounts Payable | $1.05B | $983M | $952M | $1.07B | $1.07B | $1.01B | $1.15B | $1.09B | $1.24B | $955M | · | $1.07B | $1.11B | $996M | · | $1.03B | |
| Current Liabilities | $2.62B | $2.50B | $2.39B | $2.68B | $2.80B | $2.62B | $2.72B | $2.79B | $2.75B | $2.54B | · | $2.49B | $2.39B | $2.35B | · | $2.33B | |
| Capital Leases | · | · | $116M | · | · | · | $112M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $51M | $56M | $57M | $62M | $69M | $69M | $74M | $56M | $60M | $44M | · | $43M | $32M | $30M | · | $43M | |
| Other Non-current Liabilities | $1.03B | $984M | $1.01B | $1.12B | $1.12B | $994M | $977M | $674M | $548M | $549M | · | $421M | $393M | $421M | · | $441M | |
| Total Liabilities | $12.17B | $12.09B | $12.12B | $12.65B | $12.77B | $12.61B | $12.63B | $12.26B | $12.01B | $11.84B | · | $11.60B | $11.53B | · | · | · | |
| Long-term Debt | $8.55B | $8.57B | $8.64B | $8.83B | $8.90B | $8.96B | $8.88B | $8.75B | $8.66B | $8.71B | · | $8.65B | $8.73B | $8.71B | · | $8.70B | |
| Total Debt | $8.48B | $8.55B | · | $8.78B | · | · | · | $8.75B | $8.66B | $8.71B | · | $8.65B | $8.73B | $8.71B | · | $8.70B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Retained Earnings | $1.35B | $1.25B | $1.11B | $1.32B | $1.16B | $1.03B | $1.01B | $975M | $690M | $573M | · | $-16M | $-25M | $-206M | · | $-383M | |
| AOCI | $-548M | $-539M | $-527M | $-574M | $-572M | $-617M | $-649M | $-571M | $-612M | $-577M | · | $-576M | $-533M | $-534M | · | $-686M | |
| Stockholders' Equity | $1.01B | $903M | $752M | $906M | $733M | $542M | $472M | $493M | $144M | $48M | $-70M | $-589M | $-555M | $-737M | $-892M | $-1.07B | |
| Liabilities + Equity | $13.18B | $13.00B | $12.87B | $13.55B | $13.50B | $13.16B | $13.10B | $12.75B | $12.15B | $11.89B | · | $11.01B | $10.98B | $10.76B | · | $10.44B | |
| Shares Outstanding | 262,609,000 | 262,649,000 | 260,316,000 | 259,983,000 | 259,965,000 | 257,950,000 | 257,799,000 | 257,539,000 | 257,473,000 | 255,847,000 | · | 255,606,000 | 255,568,000 | 254,432,000 | · | 254,364,000 |
Arus Kas 13
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $25M | $19M | $7M | $24M | $22M | $24M | $26M | $25M | $28M | $26M | $27M | $27M | $25M | $22M | $23M | $18M | |
| Deferred Tax | $16M | $3M | $30M | $40M | $10M | $-17M | $10M | $-196M | $21M | $5M | $-489M | $8M | $-7M | $3M | $0 | $-9M | |
| Restructuring | $0 | $31M | $7M | $0 | $2M | $86M | $8M | $0 | $0 | $23M | $58M | $0 | $0 | $4M | $17M | $11M | |
| Operating Cash Flow | $107M | $225M | $141M | $264M | $220M | $75M | $390M | $141M | $332M | $76M | $397M | $261M | $27M | $114M | $267M | $317M | |
| CapEx | $42M | $37M | $45M | $46M | $39M | $32M | $55M | $42M | $32M | $46M | $79M | $55M | $71M | $46M | $63M | $55M | |
| Investing Cash Flow | $-76M | $386M | $-65M | $-115M | $-38M | $-172M | $-296M | $-75M | $-46M | $-96M | $-81M | $-55M | $-70M | $-54M | $-61M | $-213M | |
| Debt Issued | $0 | $0 | $325M | $300M | $340M | $90M | $150M | $0 | $1.04B | $0 | $0 | $0 | · | · | · | $0 | |
| Net Debt Issued | · | $-32M | · | · | · | · | · | · | · | $-2M | · | · | · | $-252M | · | · | |
| Dividends Paid | $6M | $5M | $4M | $3M | $10M | $71M | $74M | $74M | $79M | $70M | $73M | $74M | $74M | $73M | $73M | $74M | |
| Financing Cash Flow | $-12M | $-38M | $-187M | $-76M | $-223M | $-75M | $-82M | $-78M | $-134M | $-74M | $-77M | $-78M | $-88M | $-326M | $-82M | $-77M | |
| Net Change in Cash | $16M | $542M | $-98M | $73M | $52M | $-128M | $-88M | $59M | $129M | $-118M | $279M | $88M | $-133M | $-247M | $207M | $-46M | |
| Free Cash Flow | · | $188M | · | · | · | · | · | · | · | $30M | · | · | · | $68M | · | · | |
| Levered FCF | · | $112M | · | · | · | · | · | · | · | $-82M | · | · | · | $-31M | · | · |
Profitabilitas 5
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.4% | 53.6% | · | 53.5% | · | · | · | 58.3% | 58.4% | · | · | · | · | · | · | · | |
| Net Margin | 6.9% | 10.0% | · | 10.0% | · | · | · | 22.7% | 12.1% | 12.4% | · | 3.8% | 15.0% | 11.5% | · | 14.8% | |
| Pretax Margin | 11.8% | 14.6% | · | 15.2% | · | · | · | 13.1% | 14.6% | 14.5% | · | 5.3% | 15.8% | 15.3% | · | 18.4% | |
| ROA | 0.81% | 1.1% | · | 1.2% | · | · | · | 3.0% | 1.7% | 1.8% | · | 0.54% | 2.2% | 1.7% | · | 2.1% | |
| ROE | 12.4% | 20.2% | · | 22.9% | · | · | · | -747.9% | -94.9% | -58.4% | · | -7.0% | -28.6% | -17.8% | · | -16.9% |
Likuiditas & Solvabilitas 4
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.0 | · | 1.8 | · | · | · | 1.7 | 1.6 | 1.6 | · | 1.6 | 1.7 | 1.6 | · | 1.5 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.8 | · | · | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Debt / Equity | 8.4 | 9.5 | · | 9.7 | · | · | · | 17.7 | 60.1 | 181.5 | · | -14.7 | -15.7 | -11.8 | · | -8.2 | |
| LT Debt / Equity | 8.4 | 9.5 | · | 9.7 | · | · | · | 17.7 | 60.0 | 181.4 | · | -14.7 | -15.7 | -11.8 | · | -8.2 |
Efisiensi 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | · | · | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.5 | · | · | · | 0.5 | 0.5 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Receivables Turnover | 1.0 | 1.0 | · | 1.0 | · | · | · | 0.9 | 1.0 | 1.1 | · | 1.0 | 1.0 | 1.1 | · | 1.0 |
Valuasi (TTM) 13
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.21B | $6.17B | · | $6.29B | $6.30B | $6.32B | · | $6.33B | $6.36B | $6.29B | · | $6.20B | $6.27B | $6.23B | · | $6.29B | |
| Net Income TTM | $559M | $538M | · | $751M | $786M | $842M | · | $813M | $696M | $678M | · | $704M | $880M | $986M | · | $1.13B | |
| Market Cap | $3.56B | $1.57B | · | $2.78B | · | · | · | $4.93B | $5.33B | $4.81B | · | $4.44B | $5.32B | $5.98B | · | $5.95B | |
| Enterprise Value | $10.90B | $9.01B | · | $10.89B | · | · | · | $12.91B | $13.28B | $12.95B | · | $12.68B | $13.72B | $14.24B | · | $14.15B | |
| P/E | 6.4 | 2.9 | · | 3.7 | 3.2 | 4.6 | · | 6.1 | 7.6 | 7.1 | · | 6.3 | 6.0 | 6.1 | · | 5.3 | |
| P/S | 0.6 | 0.3 | · | 0.4 | · | · | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.8 | 1.0 | · | 0.9 | |
| P/B | 3.5 | 1.7 | · | 3.1 | · | · | · | 10.0 | 37.0 | 100.2 | · | -7.5 | -9.6 | -8.1 | · | -5.6 | |
| P / Cash Flow | · | 7.0 | · | · | · | · | · | · | · | 63.3 | · | · | · | 52.5 | · | · | |
| P / FCF | · | 8.4 | · | · | · | · | · | · | · | 160.3 | · | · | · | 88.0 | · | · | |
| EV / FCF | · | 47.9 | · | · | · | · | · | · | · | 431.6 | · | · | · | 209.4 | · | · | |
| EV / Revenue | 1.8 | 1.5 | · | 1.7 | · | · | · | 2.0 | 2.1 | 2.1 | · | 2.0 | 2.2 | 2.3 | · | 2.3 | |
| Earnings Yield | 15.7% | 34.2% | · | 27.0% | 31.2% | 21.8% | · | 16.4% | 13.1% | 14.1% | · | 15.9% | 16.6% | 16.4% | · | 19.0% | |
| Payout Ratio | · | 3.4% | · | · | · | · | · | · | · | 34.8% | · | · | · | 41.2% | · | · |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Pendapatan | $6.22B | $6.40B | $6.26B | $6.17B | $6.30B |
| Margin Kotor % | 53.3% | 58.0% | — | — | — |
| Laba Bersih | $187M | $864M | $1.02B | $917M | $1.35B |
| EPS Dilusian | $0.72 | $3.33 | $3.99 | $3.59 | $5.31 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utang / Ekuitas | 11.5 | — | -125.1 | -10.0 | -6.1 |
| Rasio Lancar | 1.8 | — | 1.5 | 1.6 | 1.4 |
| Rasio Cepat | 0.8 | — | 0.8 | 0.9 | 0.8 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $538M | $764M | $548M | $662M | $1.97B |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
- Organon & Co. (OGN) Melonjak ke Level Tertinggi 52 Minggu pada Merger Sun Senilai $11,75 Miliar
- Sun Pharma Bergabung ke Meja Besar dengan Akuisisi Organon
- Sun Pharma akan mengakuisisi Organon dalam kesepakatan senilai $11,75 miliar
- Sun Pharmaceutical Akan Membeli Organon Seharga $11,75 Miliar
- Produsen obat India Sun Pharma akan membeli perusahaan AS Organon dalam kesepakatan senilai $11,75 miliar.
- Tawaran Pengambilalihan Organon (OGN) Naik Menjadi $13 Miliar, Saham Melonjak 30,9%
- Mengapa Organon (OGN) Menarik Perhatian Kabar Akuisisi Setelah Penyesuaian Harga yang Tajam
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 712 pengaju · $2.3B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 129 (+40 vs Kuartal sebelumnya) | 84 (-5 vs Kuartal sebelumnya) | 111 (-20 vs Kuartal sebelumnya) | 182 (-14 vs Kuartal sebelumnya) | +54.4M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| VANGUARD GROUP INC | $249.324.446 | 34.773.284 | 10,61% | Saham |
| Pentwater Capital Management LP | $245.074.000 | 18.100.000 | 10,43% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $204.888.878 | 15.132.118 | 8,72% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $161.259.572 | 11.909.865 | 6,86% | Saham |
| STATE STREET CORP | $130.787.883 | 9.659.371 | 5,57% | Saham |
| GOLDMAN SACHS GROUP INC | $61.746.029 | 4.560.268 | 2,63% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $55.514.404 | 4.098.808 | 2,36% | Saham |
| AQR Arbitrage LLC | $52.384.779 | 3.880.354 | 2,23% | Saham |
| PRIVATE MANAGEMENT GROUP INC | $50.668.860 | 3.742.161 | 2,16% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $46.811.327 | 3.457.262 | 1,99% | Saham |
| MILLENNIUM MANAGEMENT LLC | $46.610.502 | 3.442.430 | 1,98% | Saham |
| FIRST TRUST ADVISORS LP | $41.966.777 | 3.099.481 | 1,79% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $37.487.311 | 2.768.635 | 1,60% | Saham |
| Man Group plc | $37.147.762 | 2.743.557 | 1,58% | Saham |
| KAHN BROTHERS GROUP INC | $36.158.881 | 2.670.523 | 1,54% | Saham |
| Balyasny Asset Management L.P. | $29.742.533 | 2.196.642 | 1,27% | Saham |
| Kryger Capital LLC | $29.147.463 | 2.152.693 | 1,24% | Saham |
| ALLIANCEBERNSTEIN L.P. | $28.480.479 | 4.754.671 | 1,21% | Saham |
| Allianz Asset Management GmbH | $28.345.435 | 2.093.459 | 1,21% | Saham |
| Bank of New York Mellon Corp | $23.825.228 | 1.759.618 | 1,01% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $22.483.062 | 1.660.492 | 0,96% | Saham |
| Parallax Volatility Advisers, L.P. | $21.691.080 | 1.602.000 | 0,92% | Opsi jual |
| Capula Management Ltd | $20.494.564 | 1.513.631 | 0,87% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $19.642.478 | 1.450.700 | 0,84% | Opsi beli |
| TIG Advisors, LLC | $18.959.832 | 1.400.283 | 0,81% | Saham |
| WATER ISLAND CAPITAL LLC | $18.616.133 | 1.374.899 | 0,79% | Saham |
| ALPINE ASSOCIATES MANAGEMENT INC. | $18.214.455 | 1.345.233 | 0,78% | Saham |
| PRINCIPAL FINANCIAL GROUP INC | $17.109.198 | 1.263.604 | 0,73% | Saham |
| Westchester Capital Management, LLC | $16.872.370 | 1.246.113 | 0,72% | Saham |
| Gotham Asset Management, LLC | $13.977.518 | 1.032.313 | 0,60% | Saham |
| Cerity Partners LLC | $12.936.564 | 955.433 | 0,55% | Saham |
| GABELLI FUNDS LLC | $12.929.481 | 954.910 | 0,55% | Saham |
| Polar Asset Management Partners Inc. | $12.860.373 | 949.806 | 0,55% | Saham |
| TWO SIGMA ADVISERS, LP | $12.452.856 | 1.736.800 | 0,53% | Saham |
| GFS Advisors, LLC | $12.304.334 | 1.267 | 0,52% | Saham |
| Public Sector Pension Investment Board | $12.215.720 | 902.195 | 0,52% | Saham |
| Magnetar Financial LLC | $11.548.835 | 852.942 | 0,49% | Saham |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $11.337.110 | 837.305 | 0,48% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.173.208 | 825.200 | 0,48% | Opsi jual |
| Advisors Asset Management, Inc. | $10.539.921 | 706.429 | 0,45% | Saham |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $10.063.876 | 743.270 | 0,43% | Saham |
| TOKIO MARINE ASSET MANAGEMENT CO LTD | $9.533.514 | 704.100 | 0,41% | Saham |
| P SCHOENFELD ASSET MANAGEMENT LP | $9.036.596 | 667.400 | 0,38% | Saham |
| AMERIPRISE FINANCIAL INC | $8.656.339 | 639.316 | 0,37% | Saham |
| Sagefield Capital LP | $8.189.168 | 604.813 | 0,35% | Saham |
| Balyasny Asset Management L.P. | $8.124.000 | 600.000 | 0,35% | Opsi beli |
| CREDIT INDUSTRIEL ET COMMERCIAL | $7.920.142 | 584.944 | 0,34% | Saham |
| PICTON MAHONEY ASSET MANAGEMENT | $7.785.502 | 575.000 | 0,33% | Saham |
| AMERICAN CENTURY COMPANIES INC | $7.681.377 | 567.310 | 0,33% | Saham |
| Centiva Capital, LP | $7.511.992 | 554.800 | 0,32% | Saham |
| GABELLI & Co INVESTMENT ADVISERS, INC. | $7.429.398 | 548.700 | 0,32% | Saham |
| STATE OF WISCONSIN INVESTMENT BOARD | $7.289.774 | 538.388 | 0,31% | Saham |
| Swiss National Bank | $7.128.472 | 526.475 | 0,30% | Saham |
| Lombard Odier Asset Management (USA) Corp | $7.108.500 | 525.000 | 0,30% | Opsi beli |
| WINTON GROUP Ltd | $6.903.531 | 509.862 | 0,29% | Saham |
| FIRST MANHATTAN CO. LLC. | $6.832.920 | 504.647 | 0,29% | Saham |
| New York Life Investment Management LLC | $6.812.204 | 503.117 | 0,29% | Saham |
| Balyasny Asset Management L.P. | $6.770.000 | 500.000 | 0,29% | Opsi jual |
| Schonfeld Strategic Advisors LLC | $6.770.000 | 500.000 | 0,29% | Opsi jual |
| Verition Fund Management LLC | $6.742.866 | 497.996 | 0,29% | Saham |
| RHUMBLINE ADVISERS | $6.723.428 | 496.563 | 0,29% | Saham |
| Verition Fund Management LLC | $6.469.412 | 477.800 | 0,28% | Opsi beli |
| Alberta Investment Management Corp | $6.093.000 | 450.000 | 0,26% | Saham |
| Carmignac Gestion | $6.074.125 | 448.606 | 0,26% | Saham |
| Legal & General Group Plc | $5.757.412 | 425.215 | 0,25% | Saham |
| Quantinno Capital Management LP | $5.711.049 | 421.790 | 0,24% | Saham |
| BANK OF AMERICA CORP /DE/ | $5.680.558 | 419.539 | 0,24% | Saham |
| First Trust Capital Management L.P. | $5.293.314 | 390.939 | 0,23% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $5.290.687 | 390.745 | 0,23% | Saham |
| Squarepoint Ops LLC | $5.283.741 | 390.232 | 0,22% | Saham |
| NORGES BANK | $5.067.359 | 374.251 | 0,22% | Saham |
| READYSTATE ASSET MANAGEMENT LP | $4.764.225 | 351.863 | 0,20% | Saham |
| BlackRock, Inc. | $4.666.344 | 344.634 | 0,20% | Saham |
| CITADEL ADVISORS LLC | $4.662.621 | 344.359 | 0,20% | Saham |
| CITADEL ADVISORS LLC | $4.598.184 | 339.600 | 0,20% | Opsi jual |
| Maven Securities LTD | $4.525.068 | 334.200 | 0,19% | Saham |
| Foundry Partners, LLC | $4.501.530 | 302.319 | 0,19% | Saham |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $4.276.717 | 315.858 | 0,18% | Saham |
| FMR LLC | $4.072.981 | 300.811 | 0,17% | Saham |
| D. E. Shaw & Co., Inc. | $3.939.653 | 290.964 | 0,17% | Saham |
| CM Management, LLC | $3.723.500 | 275.000 | 0,16% | Saham |
| SECTOR GAMMA AS | $3.666.375 | 270.781 | 0,16% | Saham |
| LMR Partners LLP | $3.655.800 | 270.000 | 0,16% | Saham |
| Parallax Volatility Advisers, L.P. | $3.452.700 | 255.000 | 0,15% | Opsi beli |
| Centiva Capital, LP | $3.385.000 | 250.000 | 0,14% | Opsi jual |
| VANGUARD ASSET MANAGEMENT, Ltd | $3.360.723 | 248.207 | 0,14% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $3.310.530 | 244.500 | 0,14% | Opsi beli |
| TWO SIGMA INVESTMENTS, LP | $3.268.448 | 241.392 | 0,14% | Saham |
| PRUDENTIAL FINANCIAL INC | $3.239.607 | 239.262 | 0,14% | Saham |
| PDT Partners, LLC | $3.117.924 | 230.275 | 0,13% | Saham |
| 180 WEALTH ADVISORS, LLC | $3.065.226 | 226.383 | 0,13% | Saham |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $2.963.744 | 218.888 | 0,13% | Saham |
| Kintayl Capital LP | $2.909.069 | 214.850 | 0,12% | Saham |
| WOLVERINE ASSET MANAGEMENT LLC | $2.815.169 | 207.915 | 0,12% | Saham |
| M&G PLC | $2.575.622 | 183.973 | 0,11% | Saham |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | $2.535.663 | 187.272 | 0,11% | Saham |
| PRELUDE CAPITAL MANAGEMENT, LLC | $2.484.224 | 183.473 | 0,11% | Saham |
| Douglas Lane & Associates, LLC | $2.446.180 | 180.663 | 0,10% | Saham |
| Howard Capital Management, LLC | $2.422.672 | 178.927 | 0,10% | Saham |
| JANE STREET GROUP, LLC | $2.411.474 | 178.100 | 0,10% | Opsi beli |
Orang dalam perusahaan 27 orang dalam · 12 pejabat · 14 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Kevin Ali | Chief Executive Officer | 4 Mei 2023 M | 50.619 | 0 | 0 | $0 |
| Matthew M Walsh | Chief Financial Officer | 5 Agu 2023 M | 52.411 | 0 | 0 | $0 |
| Kathryn Dimarco | Corporate Controller | 9 Feb. 2024 M | 8.648 | 0 | 0 | $0 |
| Rachel A Stahler | Chief Information Officer | 5 Agu 2023 M | 31.781 | 0 | 0 | $0 |
| Kirke Weaver | Gen. Counsel & Corp. Secy. | 4 Mei 2023 M | 12.461 | 0 | 0 | $0 |
| Susanne Fiedler | Chief Commercial Officer | 4 Mei 2023 M | 25.191 | 0 | 0 | $0 |
| Vittorio Nisita | Head of Global Business Svcs | 4 Mei 2023 M | 10.886 | 0 | 0 | $0 |
| Sandra Milligan | Head of Research & Development | 4 Mei 2023 M | 28.599 | 0 | 0 | $0 |
| Joseph T. Morrissey Jr. | Head of Manufacturing | 4 Mei 2023 M | 21.016 | 0 | 0 | $0 |
| Aaron Falcione | Chief Human Resources Officer | 4 Mei 2023 M | 14.762 | 0 | 0 | $0 |
| Geralyn S Ritter | Head of Ext. Affairs and ESG | 4 Mei 2023 M | 10.755 | 0 | 0 | $0 |
| Deborah H Telman | EVP GC & Corporate Secretary | 4 Mei 2022 M | 7.688 | 0 | 0 | $0 |
| Deborah R Leone | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| Philip Ozuah | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| Ramona Sequeira | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| Alan Ezekowitz | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| Cynthia M Patton | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| Helene D Gayle | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| Shalini Sharp | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| Robert Essner | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| LAZARUS ROCHELLE B | Direktur | 12 Juni 2026 A | — | 0 | 0 | $0 |
| Martha E Mcgarry | Direktur | 9 Juni 2023 A | — | 0 | 0 | $0 |
| Ma. Fatima Francisco | Direktur | 9 Juni 2023 A | 3.000 | 0 | 0 | $0 |
| Grace Puma Whiteford | Direktur | 9 Juni 2023 A | — | 0 | 0 | $0 |
| COX CARRIE SMITH | Direktur | 9 Juni 2023 A | — | 0 | 0 | $0 |
| Ferreira Juan Camilo Arjona | — | 11 Agu 2026 M | 37.432 | 0 | 0 | $0 |
| Juliana Papa Drinane | — | 5 Agu 2026 S | 18.475 | 0 | 1 | $-200.307 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 80 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| FXH · First Trust Exchange-Traded AlphaDE… | 3,83% | 2.527.212 NS | 30 April 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 2,77% | 26.958 NS | 30 April 2026 | N-PORT |
| MRGR · ProShares Trust | 2,37% | 28.200 NS | 31 Mei 2026 | N-PORT |
| ARB · AltShares Trust | 2,29% | 177.141 NS | 31 Mei 2026 | N-PORT |
| EVNT · AltShares Trust | 2,18% | 20.000 NS | 31 Mei 2026 | N-PORT |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 1,96% | 14.560.000 | 8 Agu 2026 | Harian |
| HAPS · Harbor ETF Trust | 1,94% | 230.183 NS | 30 April 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,81% | 227.905 SH | 8 Agu 2026 | Harian |
| ROSC · Lattice Strategies Trust | 1,13% | 46.579 NS | 30 April 2026 | N-PORT |
| RZV · Invesco Exchange-Traded Fund Trust | 1,05% | 236.734 SH | 8 Agu 2026 | Harian |
| SCOW · Pacer Funds Trust | 0,84% | 980 NS | 30 April 2026 | N-PORT |
| IHE · iShares Trust | 0,79% | 938.448 SH | 8 Agu 2026 | Harian |
| FYT · First Trust Exchange-Traded AlphaDE… | 0,77% | 106.712 NS | 30 April 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,39% | 596.075 SH | 8 Agu 2026 | Harian |
| IJS · iShares Trust | 0,38% | 2.339.389 SH | 8 Agu 2026 | Harian |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,38% | 557.221 SH | 8 Agu 2026 | Harian |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,38% | 346.769 NS | 30 April 2026 | N-PORT |
| XJR · iShares Trust | 0,22% | 31.031 SH | 8 Agu 2026 | Harian |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,22% | 41.375 SH | 8 Agu 2026 | Harian |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,22% | 455.160 NS | 31 Mei 2026 | N-PORT |
| IJR · iShares Trust | 0,19% | 16.016.203 SH | 8 Agu 2026 | Harian |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,19% | 918.178 SH | 8 Agu 2026 | Harian |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 95.518 NS | 30 April 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,17% | 301.242 NS | 30 April 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,16% | 16.600 NS | 30 April 2026 | N-PORT |
| SAA · ProShares Trust | 0,15% | 3.111 NS | 31 Mei 2026 | N-PORT |
| ISCV · iShares Trust | 0,11% | 57.567 SH | 8 Agu 2026 | Harian |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,10% | 33.146 NS | 30 April 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 55.689 SH | 8 Agu 2026 | Harian |
| VBR · VANGUARD INDEX FUNDS | 0,08% | 3.815.685 SH | 8 Agu 2026 | Harian |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0,08% | 250.000 PA | 8 Agu 2026 | Harian |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,08% | 42.884 NS | 30 April 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,07% | 1.249.402 NS | 31 Mei 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,06% | 667.484 NS | 30 April 2026 | N-PORT |
| IYH · iShares Trust | 0,06% | 155.876 SH | 8 Agu 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 118.299 NS | 30 April 2026 | N-PORT |
| ISCB · iShares Trust | 0,05% | 11.623 SH | 8 Agu 2026 | Harian |
| FNDX · SCHWAB STRATEGIC TRUST | 0,05% | 1.032.932 NS | 31 Mei 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 17.841 NS | 30 April 2026 | N-PORT |
| REVS · Columbia ETF Trust I | 0,05% | 11.189 NS | 30 April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,05% | 781.843 SH | 8 Agu 2026 | Harian |
| FNDB · SCHWAB STRATEGIC TRUST | 0,05% | 48.654 NS | 31 Mei 2026 | N-PORT |
| SMMD · iShares Trust | 0,05% | 132.225 SH | 8 Agu 2026 | Harian |
| ESML · iShares Trust | 0,05% | 100.848 SH | 8 Agu 2026 | Harian |
| PRF · Invesco Exchange-Traded Fund Trust | 0,04% | 310.954 SH | 8 Agu 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 3.015.036 SH | 8 Agu 2026 | Harian |
| VB · VANGUARD INDEX FUNDS | 0,04% | 6.025.121 SH | 8 Agu 2026 | Harian |
| IWS · iShares Trust | 0,03% | 396.461 SH | 8 Agu 2026 | Harian |
| TILT · FlexShares Trust | 0,03% | 50.820 NS | 30 April 2026 | N-PORT |
| WSML · iShares Trust | 0,03% | 15.813 SH | 8 Agu 2026 | Harian |